18.09.2025
New Success Story:Nano4Glio
Nano4Glio aims to develop an innovative implantable device for the continuous and targeted treatment of glioblastoma
multiforme.
This biodegradable device is designed to co-deliver the gold-standard drug (temozolomide) and a MGMT protein inhibitor directly to brain tumor cells, overcoming the limitations of current GBM therapies, such as low drug bioavailability and resistance mechanisms. By enhancing drug delivery across the blood-brain barrier and enabling localized, sustained release, Nano4Glio seeks to improve therapeutic outcomes and reduce side effects for GBM patients.
Read more about the success stories of projects funded within the M-ERA.NET Calls: here
